Highlight of my day installing a new Toliet! #laughtersthebestmedicine #chronsdisease #ulcertivecolitis #survivor #sickbuthappy #IBD #inflamatoryboweldisease #istandwithyou #chronicpain #chronicillness #chronscolitisfoundationodamerica

seen from United States

seen from United Kingdom
seen from United States

seen from United States

seen from United States
seen from Germany
seen from United States
seen from China

seen from Australia
seen from United States
seen from United States
seen from United Kingdom
seen from China

seen from United States
seen from United States

seen from United Kingdom
seen from United States
seen from United States
seen from United States
seen from China
Highlight of my day installing a new Toliet! #laughtersthebestmedicine #chronsdisease #ulcertivecolitis #survivor #sickbuthappy #IBD #inflamatoryboweldisease #istandwithyou #chronicpain #chronicillness #chronscolitisfoundationodamerica
#intestines #inflamatoryboweldisease #stress #anxiety #cbd Cannabidiol in inflammatory bowel diseases: a brief overview. http://www.ncbi.nlm.nih.gov/pubmed/22815234 “CBD is a very promising compound since it shares the typical cannabinoid beneficial effects on gut lacking any psychotropic effects. For years, its activity has been enigmatic for gastroenterologists and pharmacologists, but now it is evident that this compound may interact at extra-cannabinoid system receptor sites, such as peroxisome proliferator-activated receptor-gamma. This strategic interaction makes CBD as a potential candidate for the development of a new class of anti-IBD drugs.“ #linkinbio
#intestines #inflamatoryboweldisease #stress #anxiety #cbd Cannabidiol in inflammatory bowel diseases: a brief overview. http://www.ncbi.nlm.nih.gov/pubmed/22815234 “CBD is a very promising compound since it shares the typical cannabinoid beneficial effects on gut lacking any psychotropic effects. For years, its activity has been enigmatic for gastroenterologists and pharmacologists, but now it is evident that this compound may interact at extra-cannabinoid system receptor sites, such as peroxisome proliferator-activated receptor-gamma. This strategic interaction makes CBD as a potential candidate for the development of a new class of anti-IBD drugs.“